New dyslipidemia guidelines are reshaping how clinicians identify and treat patients at risk for atherosclerotic cardiovascular disease. In this course, you’ll gain practical strategies for implementing earlier, more targeted lipid management, applying risk assessment tools, and selecting evidence-based therapies to optimize prevention and improve patient outcomes.
Learning Objectives
Learning Objectives:
- Summarize the key updates in the newly released lipid management guidelines.
- Explain the rationale for earlier treatment of dyslipidemia to reduce atherosclerotic exposure, including thresholds for initiating therapy and the importance of timely screening using tools such as lipid panels, PREVENT risk calculator, and coronary artery calcium (CAC) scoring.
- Differentiate between primary and secondary prevention strategies in dyslipidemia management, including appropriate use of statins, non-statin therapies (e.g., ezetimibe, PCSK9 inhibitors, inclisiran), lifestyle interventions, and monitoring practices for diverse patient populations.
CE certificate available upon successful completion of the post-test and program evaluation.
MN, APRN, ACNS-BC, FPCNA, AACC
Accreditation:
PCNA is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030602.
